Free Trial

Accenture (ACN) Stock Forecast & Price Target

$351.20
-2.28 (-0.65%)
(As of 01:07 PM ET)

Accenture - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
8
Buy
14

Based on 22 Wall Street analysts who have issued ratings for Accenture in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 8 have given a hold rating, and 14 have given a buy rating for ACN.

Consensus Price Target

$371.18
5.76% Upside
According to the 22 analysts' twelve-month price targets for Accenture, the average price target is $371.18. The highest price target for ACN is $445.00, while the lowest price target for ACN is $275.00. The average price target represents a forecasted upside of 5.76% from the current price of $351.20.
Get the Latest News and Ratings for ACN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Accenture and its competitors.

Sign Up

ACN Analyst Ratings Over Time

TypeCurrent Forecast
10/2/23 to 10/1/24
1 Month Ago
9/2/23 to 9/1/24
3 Months Ago
7/4/23 to 7/3/24
1 Year Ago
10/2/22 to 10/2/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
9 Buy rating(s)
Hold
8 Hold rating(s)
10 Hold rating(s)
11 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$371.18$352.33$352.74$333.24
Forecasted Upside5.76% Upside3.04% Upside15.37% Upside8.10% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ACN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Accenture Stock vs. The Competition

TypeAccentureComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.64
2.65
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside5.05% Upside1,695.68% Upside6.15% Upside
News Sentiment Rating
Positive News

See Recent ACN News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/30/2024Barclays
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$350.00 ➝ $415.00+17.77%
9/30/2024TD Cowen
4 of 5 stars
B. Bergin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$321.00 ➝ $400.00+14.38%
9/27/2024UBS Group
4 of 5 stars
K. Mcveigh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$400.00 ➝ $415.00+18.03%
9/27/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$380.00 ➝ $395.00+11.89%
9/27/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$377.00 ➝ $389.00+9.76%
9/27/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$380.00 ➝ $390.00+10.05%
9/27/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$350.00 ➝ $370.00+3.99%
9/27/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$365.00 ➝ $388.00+9.05%
9/27/2024Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$350.00 ➝ $360.00+1.18%
9/26/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Ramnani
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$329.00 ➝ $395.00+11.79%
9/24/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$376.00 ➝ $370.00+9.46%
9/20/2024Piper Sandler Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$329.00-1.86%
9/18/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$352.00 ➝ $365.00+8.62%
9/17/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$350.00 ➝ $405.00+19.35%
6/26/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$382.00 ➝ $300.00-2.35%
6/24/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Schneider
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$335.00+8.42%
6/12/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$400.00 ➝ $350.00+19.58%
6/12/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$395.00 ➝ $340.00+15.55%
6/5/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$340.00 ➝ $275.00-4.86%
5/15/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$409.00 ➝ $295.00-3.86%
3/19/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$410.00 ➝ $445.00+19.41%
1/17/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$440.00+24.10%
7/7/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$314.00 ➝ $373.00+21.10%
4/5/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
3/24/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$289.00 ➝ $294.00+8.22%
3/20/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Nolan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
12/19/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$295.00 ➝ $300.00+13.43%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:26 PM ET.


Should I Buy Accenture Stock? ACN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, September 29, 2024. Please send any questions or comments about these Accenture pros and cons to contact@marketbeat.com.

Accenture
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Accenture:

  • Accenture declared a quarterly dividend increase to $1.48 per share, indicating a strong commitment to rewarding shareholders with consistent payouts. A higher dividend can provide investors with a stable income stream, especially in uncertain market conditions.
  • Recent earnings report showed Accenture beating analyst estimates with $2.79 earnings per share for the quarter, demonstrating strong financial performance and potential for growth. This positive earnings trend can attract more investors seeking profitable opportunities.
  • Analysts anticipate Accenture posting 11.95 EPS for the current fiscal year, suggesting a positive outlook for the company's future earnings potential. Higher earnings per share can lead to increased stock value and returns for investors.
  • Accenture has a history of consistently increasing its dividend payment by an average of 12.3% annually over the last three years, showcasing financial stability and a shareholder-friendly approach. This consistent dividend growth can attract income-focused investors looking for reliable returns.
  • Despite a recent trading dip, Accenture's stock price has shown resilience with a 52-week high of $387.51, indicating strong market performance and potential for capital appreciation. A higher stock price can lead to increased wealth for investors holding Accenture shares.

Accenture
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Accenture for these reasons:

  • Accenture's stock traded down 1.7% recently, reaching $349.70, which may indicate short-term volatility and market uncertainty. Fluctuations in stock price can lead to potential losses for investors in the short term.

ACN Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Accenture is $371.18, with a high forecast of $445.00 and a low forecast of $275.00.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accenture in the last twelve months. There are currently 8 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ACN shares.

According to analysts, Accenture's stock has a predicted upside of 5.69% based on their 12-month stock forecasts.

Over the previous 90 days, Accenture's stock had 3 upgrades by analysts.

Analysts like Accenture less than other "computer and technology" companies. The consensus rating score for Accenture is 2.64 while the average consensus rating score for "computer and technology" companies is 2.65. Learn more on how ACN compares to other companies.


This page (NYSE:ACN) was last updated on 10/1/2024 by MarketBeat.com Staff
From Our Partners